GL Capital logo

GL Capital

Asia, Shanghai, China, Shanghai

Description

GL Capital is a Greater China healthcare-focused, value-driven investment management group.

Investor Profile

GL Capital has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (25%)
  • Series Unknown (25%)
  • Series A (25%)
  • Series B (25%)

Country Focus

  • China (50%)
  • The Netherlands (25%)
  • Switzerland (25%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Chemical
  • Genetics
  • Life Science
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GL Capital frequently co-invest with?

Greenwoods Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does GL Capital often collaborate with?

PT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by GL Capital?

Sangon Biotech

Shanghai, Shanghai, China

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

BiotechnologyGenetics
Series UnknownApr 19, 2023
Amount Raised: $290,440,162
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series BJun 7, 2022
Amount Raised: $72,923,803
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Series AJan 14, 2021
Amount Raised: $194,412,819
Pharmaron

Beijing, Beijing, China

Pharmaron is a contract research organization that offers research and development services for the life science industries.

BiotechnologyChemicalPharmaceutical
Series CFeb 24, 2011
Amount Raised: $40,000,000